Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Crinetics Pharmaceuticals Inc buy UBS Group AG

Crinetics Pharmaceuticals Inc
Start price
€36.65
02.07.26 / 50%
Target price
€48.33
02.07.27
Performance (%)
99.62%
Price
€73.16
07.07.26
Summary
This prediction is currently active. The BUY prediction by UBS_Group_AG for Crinetics Pharmaceuticals Inc has seen massive gains of 99.62%. This prediction currently runs until 02.07.27. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this prediction
Performance without dividends (%)
Name 1w
Crinetics Pharmaceuticals Inc 99.62%
iShares Core DAX® 1.770%
iShares Nasdaq 100 -3.500%
iShares Nikkei 225® -4.942%
iShares S&P 500 0.300%

Comments by UBS_Group_AG for this prediction

In the thread Crinetics Pharmaceuticals Inc diskutieren
Prediction Buy
Perf. (%) 99.62%
Target price 48.329
Change
Ends at 02.07.27

Crinetics Pharmaceuticals (CRNX) is now covered by UBS Group AG. They set a "buy" rating and a $55.00 price target on the stock.
Ratings data for CRNX provided by MarketBeat

UBS Group AG 
0
Report Share
02.07.26